Osaic Holdings’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5K | Buy |
2,083
+1,458
| +233% | +$18.5K | ﹤0.01% | 5147 |
|
|
2025
Q1 | $6.91K | Sell |
625
-1,044
| -63% | -$11.5K | ﹤0.01% | 5925 |
|
|
2024
Q4 | $17.8K | Buy |
1,669
+1,057
| +173% | +$11.3K | ﹤0.01% | 5386 |
|
|
2024
Q3 | $7.77K | Buy |
612
+202
| +49% | +$2.57K | ﹤0.01% | 5881 |
|
|
2024
Q2 | $6.88K | Sell |
410
-253
| -38% | -$4.25K | ﹤0.01% | 5920 |
|
|
2024
Q1 | $9.95K | Hold |
663
| – | – | ﹤0.01% | 5673 |
|
|
2023
Q4 | $9.95K | Sell |
663
-543
| -45% | -$8.15K | ﹤0.01% | 5792 |
|
|
2023
Q3 | $16.9K | Buy |
1,206
+586
| +95% | +$8.21K | ﹤0.01% | 5615 |
|
|
2023
Q2 | $6.42K | Hold |
620
| – | – | ﹤0.01% | 6139 |
|
|
2023
Q1 | $5.73K | Sell |
620
-20
| -3% | -$185 | ﹤0.01% | 6204 |
|
|
2022
Q4 | $5K | Buy |
640
+20
| +3% | +$156 | ﹤0.01% | 6274 |
|
|
2022
Q3 | $5K | Hold |
620
| – | – | ﹤0.01% | 6348 |
|
|
2022
Q2 | $5K | Buy |
620
+120
| +24% | +$968 | ﹤0.01% | 6467 |
|
|
2022
Q1 | $4K | Hold |
500
| – | – | ﹤0.01% | 6540 |
|
|
2021
Q4 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 6558 |
|